A REVIEW OF MUCORMYCOSIS FOR POST COVID-19 COMPLICATION
| Main Author: | Jeevitha lakshmi1, Senthilkumar S R1*, Venkatachalam Thangavel2*, Sattanathan Kumar3 |
|---|---|
| Format: | Article Journal |
| Terbitan: |
, 2021
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/5301433 |
Daftar Isi:
- The pandemic coronavirus disease (COVID-19) continues to be a giant downside worldwide. Severe coronavirus disease (COVID-19) is presently managed with general glucocorticoids that improves survival rate in COVID-19 patients. Sadly, the in depth use of glucocorticoids will cause secondary microorganism or fungal infections. Whereas COVID-19 associated pulmonic aspergillosis is progressively recognized than mucormycosis. Mucormycosis is associate uncommon however serious infection that screw up the course of severe COVID-19. Mucormycosis is also a critical invasive fungal infection that arises notably in diabetic patients with or while not different underlying conditions like medical specialty malignancies or the need for solid-organ transplantation. Rhino-orbito-cerebral involvement is that the first website of mucormycosis, however the scarcity of signs may even be a reason for delayed identification. Contemporaneous hormone medical care most likely heightens the danger of mucormycosis. A high index of distrust and aggressive management is needed to boost outcomes.